Finance

Beta
Roʻyxatlar
Aksiyalar sektorlari
Belgilar
Belgilar
Narxi
Oʻzgartirishlar
Dinamika (%)
Trend
Avvalgi yopilish narxi
Ochish
Yuqori
Past
Hajmi
Bozor kapitali
SIXB
Materials
SIXB
Materials
SIXB
-0,32%
1 100,57
-3,53
-0,32%
1 104,101 103,921 108,751 097,16
SIXC
Communications
SIXC
Communications
SIXC
+0,16%
605,15
+0,99
+0,16%
604,16604,16610,19604,12
SIXE
Energy
SIXE
Energy
SIXE
-0,22%
1 195,19
-2,62
-0,22%
1 197,811 200,581 213,071 192,02
SIXI
Industrials
SIXI
Industrials
SIXI
-0,03%
1 739,91
-0,50
-0,03%
1 740,411 739,551 750,271 730,60
SIXM
Financials
SIXM
Financials
SIXM
+0,65%
638,56
+4,12
+0,65%
634,44633,13639,87633,01
SIXR
Staples
SIXR
Staples
SIXR
-1,11%
831,57
-9,33
-1,11%
840,90839,53841,73831,10
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,82%
213,36
-1,77
-0,82%
215,13215,13215,85213,24
SIXT
Technology
SIXT
Technology
SIXT
+0,17%
3 234,18
+5,47
+0,17%
3 228,713 225,623 235,433 198,95
SIXU
Utilities
SIXU
Utilities
SIXU
-0,02%
935,65
-0,22
-0,02%
935,87938,37942,00935,65
SIXV
Health care
SIXV
Health care
SIXV
-0,54%
1 449,26
-7,86
-0,54%
1 457,121 452,741 466,881 449,18
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0,72%
2 382,45
-17,39
-0,72%
2 399,842 389,712 394,612 371,22
038290:KOSDAQ
Macrogen Inc
16 900,00 ₩
-0,88%
(-150,00) 1K
28-apr, 15:30:30 (GMT+9)  ·   KRW
Barcha belgilar
BelgiNarxiOʻzgartirishlarDinamika (%)
038290 tikeri uchun statistika yaratilmoqda...
Ochish
17 050 ₩
Yuqori
17 050 ₩
Past
16 900 ₩
Bozor kapitali
183,22 mlrd
Oʻrtacha hajm
30,74 ming
Hajmi
18,50 ming
Dividend
2,96%
Choraklik dividendlar
125 ₩
Eks-dividend sanasi
27-dek, 2024
P/E koeffitsiyenti
90,25
52 haftalik eng yuqori
20 900 ₩
52 haftalik eng past
14 720 ₩
Aksiya boʻyicha daromad
187 ₩
Muomaladagi aksiyalar
10,84 mln
Xodimlar soni
475
Yangiliklar
Internetdagi manbalardan
Profil
Macrogen, Inc. is a South Korean public biotechnology company. The company's headquarters are located in Seoul. The company was founded in 1997 by Jeong-sun Seo, a professor at Seoul National University. It was venture capital-backed until its initial public offering and subsequent listing on the KOSDAQ market in 2000, making it the first Korean biotechnology firm to raise funds through an IPO. The company announced plans in 2010 to map the "Korean genome" based on the notion that United States-backed genome mapping efforts up to that time were representative of the "Caucasian genome" rather than the "Human genome" as claimed. By 2015, the company was described by one news outlet as "a global leader in personalized genomic medicine". Wikipedia
Macrogen Inc haqida
CEOSeo Jeong-seon
Xodimlar soni475
Asos solingan5-iyn, 1997
Bosh ofislar-
Sektor-
Veb-saytmacrogen.com
Avvalgi hisobotlarBarcha qiymatlar – KRW
Loading Previous Earnings...
Daromad hisoboti
Daromad
Sof foyda
Barcha qiymatlar – KRW
mar, 2025
iyn, 2025
sen, 2025
dek, 2025
Daromad
40,96 mlrd
48,99 mlrd
49,06 mlrd
56,26 mlrd
Sotilgan mahsulotning tannarxi
27,02 mlrd
32,32 mlrd
30,68 mlrd
35,05 mlrd
Daromad narxi
27,02 mlrd
32,32 mlrd
30,68 mlrd
35,05 mlrd
Tadqiqot va ishlanmalarga xarajatlar
-
-
-
4,12 mlrd
Tadqiqot va ishlanmalarga xarajatlar jami xarajatlar
-
-
-
-
Tijoriy, umumiy va maʼmuriy xarajatlar
16,59 mlrd
17,35 mlrd
17,10 mlrd
6,79 mlrd
Operatsion xarajatlar
16,98 mlrd
18,19 mlrd
17,27 mlrd
17,57 mlrd
Jami operatsion xarajatlar
44,01 mlrd
50,51 mlrd
47,95 mlrd
52,62 mlrd
Operatsion daromad
-3,05 mlrd
-1,53 mlrd
1,11 mlrd
3,64 mlrd
Boshqa nooperatsion daromad
-64,46 mln
-696,27 mln
985,86 mln
2,18 mlrd
Soliq toʻlangunga qadar foyda, shu jumladan gʻayrioddiy moddalar
-3,22 mlrd
-2,32 mlrd
2,04 mlrd
3,49 mlrd
Soliq toʻlangunga qadar foyda, gʻayrioddiy moddalar bundan mustasno
-3,22 mlrd
-2,32 mlrd
2,04 mlrd
2,30 mlrd
Daromad soligʻi boʻyicha xarajat
-44,67 mln
-55,36 mln
-46,70 mln
339,81 mln
Amaldagi soliq stavkasi
1,39%
2,39%
-2,28%
9,75%
Boshqa operatsion xarajatlar
-
-
-
1,37 mlrd
Sof foyda
-2,22 mlrd
-1,59 mlrd
2,46 mlrd
3,38 mlrd
Sof foyda marjasi
-5,42%
-3,24%
5,01%
6,00%
Har bir aksiya foydasi
-
-
-
-
Foizlar va investitsiyalardan olingan daromadlar
-
-
-
748,82 mln
Foizlarni toʻlash xarajatlari
-
-
-
-2,52 mlrd
Foizlarni toʻlash boʻyicha sof xarajatlar
-
-
-
-1,77 mlrd
Amortizatsiya ajratmalari
-
-
-
3,66 mlrd
EBITDA
-346,40 mln
1,17 mlrd
3,81 mlrd
7,98 mlrd
Aktivlarni sotishdan olingan foyda yoki zarar
-
-
-
88,53 mln
AI kontentda xatolar boʻlishi mumkin. Batafsil

Tahlil

Vazifalarim
Hali vazifa yaratmagansiz
Vazifalaringiz shu yerda chiqadi. Vazifalarni rejalashtiring va Google Finance xizmatidan foydalaning.
Andozalar
Kuzatuv roʻyxati brifingi
Kuzatuv roʻyxatining kunlik bozor oldidan tahlili
Kelgusi tushumlar
Hafta ichida kelgusi tushum hisobotlari
Anomal volatillik va hajm
Bugun erta ogohlantirish: volatillik va hajm
AI kontentda xatolar boʻlishi mumkin. Batafsil